Detalles de la búsqueda
1.
Enhancing global access to cancer medicines.
CA Cancer J Clin
; 70(2): 105-124, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32068901
2.
Real-world treatment patterns and clinical outcomes in patients treated with eribulin after prior phosphoinositide 3-Kinase inhibitor treatment for metastatic breast cancer.
Breast Cancer Res Treat
; 205(1): 201-210, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310616
3.
Abemaciclib plus fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in premenopausal women: subgroup analysis from the MONARCH 2 trial.
Breast Cancer Res
; 23(1): 87, 2021 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34425869
4.
Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registry.
Breast Cancer Res Treat
; 188(1): 179-190, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33641083
5.
Health-Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine Therapy.
Oncologist
; 25(2): e243-e251, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32043763
6.
De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry.
Oncologist
; 25(2): e214-e222, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32043771
7.
Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine.
Breast Cancer Res Treat
; 184(2): 559-565, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32808239
8.
Plasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancer.
Breast Cancer Res Treat
; 182(3): 665-677, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32562118
9.
Health Through Activity: Initial Evaluation of an In-Home Intervention for Older Adults With Cancer.
Am J Occup Ther
; 73(5): 7305205070p1-7305205070p11, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31484031
10.
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.
Lancet Oncol
; 19(6): 812-824, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29706375
11.
Incongruence between women's survey- and interview-determined decision control preferences: A mixed methods study of decision-making in metastatic breast cancer.
Psychooncology
; 27(8): 1950-1957, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29714044
12.
Goal Attainment and Goal Adjustment of Older Adults During Person-Directed Cancer Rehabilitation.
Am J Occup Ther
; 72(2): 7202205110p1-7202205110p8, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29426388
13.
Correction to: Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine.
Breast Cancer Res Treat
; 187(2): 603, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33907908
14.
"New" metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapy.
Breast Cancer Res
; 17(1): 150, 2015 12 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27391598
15.
The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831.
Breast Cancer Res
; 17(1): 133, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26429296
16.
Quantitative measurement of HER2 expression in breast cancers: comparison with 'real-world' routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival.
Breast Cancer Res
; 17: 41, 2015 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25886996
17.
Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial.
Breast Cancer Res Treat
; 154(3): 509-20, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26567010
18.
Development and initial evaluation of a telephone-delivered, behavioral activation, and problem-solving treatment program to address functional goals of breast cancer survivors.
J Psychosoc Oncol
; 33(2): 199-218, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25668509
19.
Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer.
Cancer
; 120(17): 2657-64, 2014 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24930388
20.
Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies.
Breast Cancer Res Treat
; 148(3): 553-61, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25381136